BackBlueprint Medicines Overview

Blueprint Medicines Cost of Revenue

Cost of Revenue analysis for BPMC.

Quarterly Cost of Revenue

$2.80M
↓ 64.98% YoY

As of Mar 31, 2025

Annual Cost of Revenue (TTM)

$19.77M
↑ 18.63% YoY

Trailing 12 months ending Mar 31, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin